The Efficacy and Safety of Apatinib Monotherapy in Maintenance Treatment of Extensive-stage Small-cell Lung Cancer

NCT03129698 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
52
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Junling Li